IFN-α induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2

Journal of Immunology

Volumn 157, Issue 2, 1996, Pages 522-528

  Chakrabarti, Debasis ^a   Hultgren, Bruce ^a   Stewart, Timothy A ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; CD86 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; ETIOLOGY; GENE EXPRESSION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TRANSGENIC ANIMAL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD86; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-ALPHA; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 0029979838     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Muir, A., D. A. Schatz, and N. K. Maclaren. 1992. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus. Endocrinol. Metab. Clin. North Am. 21:199.
2. Roep, B. O., S. D. Arden, R. R. de Vries, and J. C. Hutton. 1990. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 345:632.
3. Harrison, L. C., H. De Aizpurua, T. Loudovaris, I. L. Campbell, J. S. Cebon, B. D. Tait, and P. G. Colman. 1991. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes 40:1128.
4. Atkinson, M. A., D. L. Kaufman, L. Campbell, K. A. Gibbs, S. C. Shah, D. F. Bu, M. G. Erlander, A. J. Tobin, and N. K. Maclaren. 1992. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet. 339:458.
5. Koevary, S., A. Rossini, W. Stoller, W. Chick, and R. M. Williams. 1983. Passive transfer of diabetes in the BB/W rat. Science 220:727.
6. Wicker, L. S., B. J. Miller, and Y. Mullen. 1986. Transfer of autoimmune diabetes mellitus with splenocytes from non obese diabetic (NOD) mice. Diabetes 35:855.
7. Peterson, J. D., B. Pike, M. McDuffie, and K. Haskins. 1994. Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice. J. Immunol. 153: 2800.
8. Jameson, S. C., K. A. Hogquist, and M. J. Bevan. 1995. Positive selection of thymocytes. Annu. Rev. Immunol. 13:93.
9. Bretscher, P., and M. Cohen. 1970. A theory of self-nonself discrimination. Science 169:1042.
10. Letvin, N. L., I. J. Fox, M. I. Greene, B. Bennaceraf, and R. N. Germain. 1980. Immunologic effects of whole body ultra violet irradiation. II. Defect in splenic adherent cell antigen presentation for stimulation of T cell proliferation. J. Immunol. 135:2953.
11. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
12. Van Seventer, G. A., Y. Shimizu, K. J. Horgan, and S. Shaw. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:4579.
13. Mincheff, M. S., and H. T. Meryman. 1990. Costimulatory signals necessary for induction of T cell proliferation. Transplantation 49:768.
14. Linsley, P. S., W. Brady, L. Grosmaire, A. Aruffo, N. K. Damle, and J. A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation J. Exp. Med. 173:721.
15. + T cells. J. Exp. Med 173:759.
16. Gimmi, C. D., G. J. Freeman, J. G. Gribben, K. Sugita, A. S. Freedman, C. Morimoto, and L. M. Nadler. 1991. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88:6575.
17. Demotz, S., H. M. Grey, and A. Sette A. 1990. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science. 249:1028.
18. Foulis, A. K., M. A. Farquharson, and A. Meager. 1987. Immunoreactive alpha-interferon in insulin-secreting beta cells in type I diabetes mellitus. Lancet 2:1423.
19. Huang, X., J. Yuan, A. Goddard, A. Foulis, R. F. L. James, A. Lernmark, R. Pujo-Borrell, A. Rabinovitch, N. Somoza, and T. A. Stewart. 1995. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 44:658.
20. Stewart, T. A., B. Hultgren, X. Huang, S. Pitts-Meek, J. Hully, and N. J. MacLachlan. 1995. Induction of type I diabetes by interferon-α in transgenic mice. Science 260:1942.
21. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
22. Staehelin, T., B. Durrer, J. Schmidt, B. Takacs, J. Stocker, V. Miggiano, C. Stahli, M. Rubinstein, W. P. Levy, R. Hershberg, and S. Pestka. 1981. Production of hybridomas secreting monoclonal antibodies to the human leukocyte interferons. Proc. Natl. Acad. Sci. USA 78:1848.
23. Rabinovitch, A. 1993. Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Rev. 1:215.
24. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
25. Weber, J. S., and S. A. Rosenberg. 1988. Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro. Cancer Res. 48: 5818.
26. Shehadeh, N. N., F. LaRosa, and K. J. Lafferty. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmunity 6:291.
27. Holan, V., K. Kohno, and J. Minowada. 1995. Natural human interferon-alpha augments interleukin-2 production by a direct action on the activated IL-2-producing T cells. J. Int. Res. 11:319.
28. + T cells. J. Exp. Med. 178:1655.
29. + T cells: ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J. Immunol. 155:45.
30. Lanier, L. L., S. O'Fallon, C. Somoza, J. H. Phillips, P. S. Linsley, K. Okumura, D. Ito, and M. Azuma M. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
31. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
32. Guerder, S., D. E. Picarella, P. S. Linsley, and R. Flavell. 1994. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91:5138.
33. Harlan, D. M., M. A. Barnett, R. Abe, K. Pechhold, N. B. Patterson, G. S. Gray, and C. H. June. 1995. Very-low-dose streptozotocin induces diabetes in insulin promoter-mB7-1 transgenic mice. Diabetes 44:816.
34. Huang, X., B. Hultgren, N. Dybdal, and T. A. Stewart. 1994. Islet expression of interferon-α precedes diabetes in both the BB rat and streptozotocin treated mice. Immunity 1:469.
35. Dustin, M. L., R. Rothlein, A. K. Bhan, C. A. Dinarello, and T. A. Springer. 1986. Induction by IL-1 and interferon-γ. tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137:245.
36. Stack, R. M., D. J. Lenschow, G. S. Gray, J. A. Bluestone, and F. W. Fitch. 1994. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J. Immunol. 152:5723.
37. Larsen, C. P., S. C. Ritchie, R. Hendrix, P. S. Linsley, K. S. Hathcock, R. J. Hodes, R. P. Lowry, and T. C. Pearson. 1994. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152:5208.
38. Janeway C. 1989. Immunogenicity signals 1, 2, 3..... and 0. Immunol. Today 10:283.
39. Hooks, J. J., H. M. Moutsopoulos, S. A. Geis, N. I. Stahl, J. L. Decker, and A. L. Notkins. 1979. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301:5.
40. Preble, O. T., R. J. Black, R. M. Friedman, J. H. Klippel, and J. Vilcek. 1982. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 216:429.
41. Ytterberg, S. R., and T. J. Schnitzer. 1982. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 25:401.
42. Ritter, K., R. J. Kuhl, F. Semrau, H. Eiffert, H. D. Kratzin, and R. Thomssen. 1994. Manganese superoxide dismutase as a target of autoantibodies in acute Epstein-Barr virus infection. J. Exp. Med. 180:1995.
43. Neumann, D. A., N. R. Rose, A. A. Ansari, and A. Herskowitz. 1994. Induction of multiple heart autuantibodies in mice with Coxsackievirus B3 and cardiac myosin-induced autoimmune myocarditis. J. Immunol. 152:343.
44. Wong, G. H., I. Clark-Lewis, L. McKimm-Breschkin, A. W. Harris, and J. W. Schrader. 1983. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on lymphoid, macrophage, and myeloid cell lines. J. Immunol. 131:788.
45. Elson, C. J., R. N. Barker, S. J. Thompson, and N. A. Williams. 1995. Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol Today, 16:71.
46. Rocha, B., A. Grandien, and A. A. Freitas. 1995. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J. Exp. Med. 181:993.
47. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:314.
48. Ramsdell, F., M. S. Seaman, R. E. Miller, T. W. Tough, M. R. Alderson, and D. H. Lynch. 1994. gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 24:928.
49. Watanabe, D., T. Suda, H. Hashimoto, and S. Nagata S. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14:12.
50. + T-cells from diabetic versus prediabetic NOD. NON-Thy-1a donors. Diabetes 42:44.
51. Kabelitz, D., T. Pohl, and K. Pechhold. 1993. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol. Today, 14:338.
52. Asamoto, H., M. Oishi, and Y. Akazawa. 1986. Histologic and immunologic changes in the thymus and other organs in NOD mice. In Insulitis and Type 1 Diabetes: Lessons from the NOD Mouse. S. Tarui, Y. Tochino, and K. Nonaka, eds. Academic Press, Tokyo, Japan, pp. 61-71.
53. Ronnblom, L. E., G. Alm, and K. E. Oberg. 1990. Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J. Intern. Med. 227:207.
54. Fabris, P., C. Betterle, A. Floreani, N. A. Greggio, F. de Lazzari, R. Naccarato, and M. Chiaramonte. 1992. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet 340:548.
55. Guerci, A. P., B. Guerci, C. Levy-Marchal, J. Ongagna, O. Ziegler, H. Candiloros, O. Guerci, and P. Drouin. 1994. Onset of insulin-dependent diabetes mellitus after interferon-alpha therapy for hairy cell leukaemia. Lancet 343: 1167.
56. Mathieu, E., O. Fain, M. Sitbon, and M. Thomas. 1995. Autoimmune diabetes after treatment with interferon-alpha. Presse Med. 24:238.